The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 23, 2006

Filed:

Mar. 07, 2001
Applicants:

Raymond Kaempfer, Jerusalem, IL;

Farhat Osman, Sakhnin, IL;

Nayef Jarrous, Shefaram, IL;

Yitzhak Ben-asouli, Kfar Hanagid, IL;

Inventors:

Raymond Kaempfer, Jerusalem, IL;

Farhat Osman, Sakhnin, IL;

Nayef Jarrous, Shefaram, IL;

Yitzhak Ben-Asouli, Kfar Hanagid, IL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); C12N 15/09 (2006.01); C12N 15/63 (2006.01); C12N 15/70 (2006.01); C12N 15/74 (2006.01);
U.S. Cl.
CPC ...
Abstract

A cis-acting nucleotide sequence which is capable of rendering the removal of introns from a precursor transcript encoded by a gene, which gene harbors at least one such cis-acting nucleotide sequence, occurring during the production of mRNA of a gene, dependent upon activation of a trans-acting factor. The trans-acting factor is an RNA-activated protein kinase which is capable of phosphorylating the α-subunit of eukaryotic initiation factor 2. The trans-acting factor is preferably, the RNA-activated protein kinase (PKR). The cis-acting nucleotide sequence can be derived from the 3' untranslated region of the human tumor necrosis factor α gene (TNF-α3′-UTR) and may comprise the nucleotide sequence as denoted by SEQ ID NO:1 or biologically functional fragments, derivatives, mutants and homologues thereof.


Find Patent Forward Citations

Loading…